Statins for Prevention of Contrast Induced Nephropathy
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
In this randomized study the investigators wish to explore the role of pre-procedural statin
therapy for the prevention of contrast induced nephropathy in patients with
moderate-to-severe renal dysfunction, submitted to elective coronary or angioplasty.